Lupin appoints Jon Stelzmiller to head US specialty business

Homegrown pharma major Lupin on September 25 announced appointment of Jon Stelzmiller as the President of its US specialty business.

Stelzmiller, who was most recently Senior Vice-President and General Manager - Women's Healthcare at Bayer, will be replacing Nicholas Hart, Lupin said in a statement.

"Jon's extensive experience in the pharmaceutical industry, particularly in women's health segment in the US, will be a great asset for Lupin as we build our specialty business," Lupin CEO Vinita Gupta said.

He brings over 30 years of experience in specialty segment and has a proven track record of building high performing teams and launching 18 major brands across 14 different therapeutic areas, including women's health, oncology and anti-infectives, the statement said.

Prior to joining Bayer, Jon spent 12 years at Pfizer Inc. He spent his early career at the Upjohn Company and Pharmacia Corporation in various sales and sales leadership positions.

He holds a Bachelor of Science degree in Bacteriology from North Dakota State University, it said.

IRCTC IPO to launch on Sep 30: All you need to know

PMC Bank crisis: Rs 2,500-crore loan to HDIL biggest reason behind RBI clampdown, says report